Metropolitan Health Networks (NYSE: MDF) reported earnings on May 8. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended March 31 (Q1), Metropolitan Health Networks beat slightly on revenues and missed estimates on earnings per share.

Compared with the prior-year quarter, revenue improved significantly and GAAP earnings per share dropped.

Margins dropped across the board.

Revenue details
Metropolitan Health Networks reported revenue of $195.2 million. The two analysts polled by S&P Capital IQ foresaw a top line of $192.1 million on the same basis. GAAP reported sales were much higher than the prior-year quarter's $94.7 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at $0.18. The two earnings estimates compiled by S&P Capital IQ predicted $0.20 per share. GAAP EPS of $0.18 for Q1 were 5.3% lower than the prior-year quarter's $0.19 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 19.4%, 90 basis points worse than the prior-year quarter. Operating margin was 10.9%, 260 basis points worse than the prior-year quarter. Net margin was 4.1%, 430 basis points worse than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $195.7 million. On the bottom line, the average EPS estimate is $0.24.

Next year's average estimate for revenue is $771.8 million. The average EPS estimate is $0.91.

Investor sentiment
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 223 members out of 235 rating the stock outperform, and 12 members rating it underperform. Among 32 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 28 give Metropolitan Health Networks a green thumbs-up, and four give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Metropolitan Health Networks is buy, with an average price target of $9.65.

The health-care investing landscape is littered with also-rans and a few major winners. Is Metropolitan Health Networks prepared for the future? Read "Discover the Next Rule-Breaking Multibagger" to learn about a company David Gardner believes will deliver amazing returns during the next few years. Get instant access to this free report.